Cargando…
Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”
Autores principales: | Lu, Jianqin, Liu, Xiangsheng, Liao, Yu-Pei, Wang, Xiang, Ahmed, Ayman, Jiang, Wen, Ji, Ying, Meng, Huan, Nel, Andre E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887877/ https://www.ncbi.nlm.nih.gov/pubmed/34018715 http://dx.doi.org/10.1021/acsnano.0c08653 |
Ejemplares similares
-
Breast
Cancer Chemo-immunotherapy through Liposomal
Delivery of an Immunogenic Cell Death Stimulus Plus Interference in
the IDO-1 Pathway
por: Lu, Jianqin, et al.
Publicado: (2018) -
Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1
por: Liu, Xiangsheng, et al.
Publicado: (2021) -
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
por: Lu, Jianqin, et al.
Publicado: (2017) -
Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models
por: Shi, Xiaowei, et al.
Publicado: (2023) -
Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
por: Zhang, Jiulong, et al.
Publicado: (2022)